It has an interesting survival mechanism: it uses mucin as its primary carbon and nitrogen source
As of January 2026, the Wegovy Pill (oral semaglutide 25 mg) is FDA-approved and available in the US
Sun A, Chang JY, Wang YP, Cheng SJ, Chen HM, Chiang CP
After consideration of public comments we received, we are finalizing our proposal to use scaled OPPS relative weights to establish ASC relative payment weights and to use the ratio of CY 2025 to CY 2026 total payments (the weight scalar) to scale the ASC relative payment weights for CY 2026
Specifically, a few commenters requested that CMS maintain the CY 2025 per day cost threshold of $630 and not update the cost threshold according to the proposed methodology for CY 2026
10.1002/hep.23203 Hepatology (Baltimore M